# Novira Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novira-therapeutics

- Industry: Biotechnology
- Headquarters: Doylestown, US
- Website: www.noviratherapeutics.com
- Total disclosed funding: $53M
- Latest round: Series A (Feb 11, 2014)
- Investors on record: 8

## About

Established in 2009, Novira Therapeutics is based in Pennsylvania, US and operates as an anti-viral drug discovery company focused on the discovery of novel, first-in-class therapeutics for the treatment of HBV and HIV.

## Funding rounds

- Series A, Feb 11, 2014, $28M — Versant Ventures, Canaan Partners, 5AM Ventures, BioAdvance, Robin Hood Ventures, MAG Fund, Delaware Crossing Investor Group, 6 Dimensions Capital
- Series A, Mar 25, 2013, $7.5M — Versant Ventures, Canaan Partners, 5AM Ventures
- Series A, Oct 9, 2012, $3.3M — Canaan Partners
- Series A, Aug 24, 2012, $11M — Canaan Partners, 5AM Ventures, BioAdvance, Robin Hood Ventures, MAG Fund, Delaware Crossing Investor Group, 6 Dimensions Capital
- Seed, Jul 26, 2011, $2.5M — BioAdvance, Robin Hood Ventures, MAG Fund, Delaware Crossing Investor Group
- Seed, Mar 30, 2009, $0.5M — BioAdvance

## Investors

- BioAdvance (https://capitalatlas.ai/funds/bioadvance) — Seed, Series A
- Robin Hood Ventures (https://capitalatlas.ai/funds/robin-hood-ventures) — Seed, Series A
- MAG Fund — Seed, Series A
- Delaware Crossing Investor Group — Seed, Series A
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series A
- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series A
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A